MAPT and Alzheimer disease: LPAs have been demonstrated to promote the GSK3β-mediated microtubule depolymerization, neurite extension and axon differentiation by regulating tau phosphorylation under physiological and pathological conditions such as brain development and AD, respectively (Hao et al., 2020).